The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Laboratory Corporation of America Holdings

NYSE: LH
Last

(U.S.) $150.34

Today's change+4.13 +2.82%
Updated June 22 4:02 PM EDT. Delayed by at least 15 minutes.
 

Laboratory Corporation of America Holdings

NYSE: LH
Last

(U.S.) $150.34

Today's change+4.13 +2.82%
Updated June 22 4:02 PM EDT. Delayed by at least 15 minutes.

Laboratory Corporation of America Holdings Hits New 52-week High

Laboratory Corporation of America Holdings closed up sharply Thursday, rallying (U.S.)$4.13 or 2.82% to (U.S.)$150.34 and setting a new 52-week high. Over the last five days, shares have gained 7.08% and are currently 1.40% off of the 52-week high. Shares have performed in-line with the S&P 500 during the last year.

Key company metrics

  • Open(U.S.) $146.11
  • Previous close(U.S.) $146.21
  • High(U.S.) $152.47
  • Low(U.S.) $145.89
  • Bid / Ask(U.S.) $144.74 / (U.S.) $0.00
  • YTD % change+17.11%
  • Volume1,484,126
  • Average volume (10-day)748,095
  • Average volume (1-month)690,981
  • Average volume (3-month)736,805
  • 52-week range(U.S.) $119.51 to (U.S.) $152.47
  • Beta0.95
  • Trailing P/E20.71×
  • P/E 1 year forward15.50×
  • Forward PEG1.82×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $7.26
Updated June 22 4:02 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+7.83%

Based on its net profit margin of 7.83%, Laboratory Corporation of America Holdings is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.47%Sector:HealthcareIndustry:Healthcare Facilities
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2017Q4/2016Q3/2016Q2/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016
Revenue2,4472,4282,4152,431
Total other revenue--------
Total revenue2,4472,4282,4152,431
Gross profit804788788827
Total cost of revenue1,6431,6401,6261,604
Total operating expense2,1142,1052,0912,064
Selling / general / administrative419406401408
Research & development--------
Depreciation / amortization48494145
Interest expense (income), net operating--------
Unusual expense (income)410237
Other operating expenses, total--------
Operating income333323324367
Interest income (expense), net non-operating-52-53-58-54
Gain (loss) on sale of assets--------
Other--------
Income before tax280277263313
Income after tax193185180199
Income tax, total879284115
Net income192184180198
Total adjustments to net income--------
Net income before extra. items192184180198
Minority interest0000
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items192184180198
Inc. avail. to common incl. extra. items192184180198
Diluted net income192184180198
Dilution adjustment--------
Diluted weighted average shares104105105104
Diluted EPS excluding extraordinary itemsvalue per share1.841.761.711.91
Dividends per sharevalue per share0.00--0.000.00
Diluted normalized EPSvalue per share1.871.831.861.95